G.S.C. Chiang

1.3k total citations
41 papers, 997 citations indexed

About

G.S.C. Chiang is a scholar working on Nephrology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, G.S.C. Chiang has authored 41 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 10 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in G.S.C. Chiang's work include Renal Diseases and Glomerulopathies (18 papers), Breast Lesions and Carcinomas (6 papers) and Global Cancer Incidence and Screening (5 papers). G.S.C. Chiang is often cited by papers focused on Renal Diseases and Glomerulopathies (18 papers), Breast Lesions and Carcinomas (6 papers) and Global Cancer Incidence and Screening (5 papers). G.S.C. Chiang collaborates with scholars based in Singapore, United States and Malaysia. G.S.C. Chiang's co-authors include Keng Thye Woo, Hui‐Kim Yap, Puay Hoon Tan, Stanley C. Jordan, Keng-Thye Woo, Kok‐Seng Wong, Puay‐Hoon Tan, Changli Wei, Li-Kiang Tan and Caroline Lee and has published in prestigious journals such as Cancer, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

G.S.C. Chiang

40 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.S.C. Chiang Singapore 17 490 180 166 160 147 41 997
Maddalena Marasà United States 14 826 1.7× 235 1.3× 242 1.5× 266 1.7× 73 0.5× 28 1.5k
F M Lai Hong Kong 15 432 0.9× 113 0.6× 90 0.5× 58 0.4× 45 0.3× 30 874
Yasemin Özlük Türkiye 18 247 0.5× 66 0.4× 280 1.7× 270 1.7× 147 1.0× 118 1.0k
Magali Colombat France 21 278 0.6× 107 0.6× 413 2.5× 359 2.2× 181 1.2× 92 1.5k
Giacomo Quattrocchio Italy 17 421 0.9× 94 0.5× 186 1.1× 115 0.7× 40 0.3× 52 836
Philippe Rouvier France 15 142 0.3× 80 0.4× 169 1.0× 367 2.3× 231 1.6× 45 964
Frank B. Cortazar United States 16 357 0.7× 146 0.8× 602 3.6× 138 0.9× 594 4.0× 40 1.3k
Wan-zhong Zou China 17 737 1.5× 174 1.0× 417 2.5× 60 0.4× 75 0.5× 49 1.2k
Haiyan Wang China 14 359 0.7× 149 0.8× 320 1.9× 85 0.5× 227 1.5× 54 939
Akinari Sekine Japan 12 272 0.6× 68 0.4× 154 0.9× 110 0.7× 112 0.8× 113 667

Countries citing papers authored by G.S.C. Chiang

Since Specialization
Citations

This map shows the geographic impact of G.S.C. Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.S.C. Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.S.C. Chiang more than expected).

Fields of papers citing papers by G.S.C. Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.S.C. Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.S.C. Chiang. The network helps show where G.S.C. Chiang may publish in the future.

Co-authorship network of co-authors of G.S.C. Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of G.S.C. Chiang. A scholar is included among the top collaborators of G.S.C. Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.S.C. Chiang. G.S.C. Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosen, Eric L., Jennifer L. Caswell‐Jin, David Berz, et al.. (2024). 367P Phase I/II dose escalation study evaluating first-in-class eIF4A inhibitor zotatifin in ER+ metastatic breast cancer. Annals of Oncology. 35. S372–S372. 1 indexed citations
2.
Woo, Keng-Thye, Marjorie Foo, Anantharaman Vathsala, et al.. (2010). Global Evolutionary Trend of the Prevalence of Primary Glomerulonephritis over the Past Three Decades. Nephron Clinical Practice. 116(4). c337–c346. 49 indexed citations
3.
Teng, Yvonne, Kezhi Mao, Alwin Hwai Liang Loh, et al.. (2009). Glomerular basement membrane thickness in an Asian population using a novel image analysis software. Pathology. 41(4). 342–347. 3 indexed citations
4.
Woo, Keng Thye, H. K. Tan, Marjorie Foo, et al.. (2009). Beneficial effects of high-dose losartan in IgA nephritis. Clinical Nephrology. 71(6). 617–624. 27 indexed citations
5.
Liew, Adrian, G.S.C. Chiang, & Anantharaman Vathsala. (2008). Factors associated with proteinuria in renal transplant recipients treated with sirolimus. Transplant International. 22(3). 313–322. 10 indexed citations
6.
Wei, Changli, Li-Kiang Tan, Puay‐Hoon Tan, et al.. (2007). Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in Rats. Journal of the American Society of Nephrology. 18(5). 1476–1485. 168 indexed citations
7.
Yan, Tristan D., G.S.C. Chiang, Jiali Zhao, Dedrick Kok Hong Chan, & David L. Morris. (2005). Lung metastases after liver resection or cryotherapy for hepatic metastasis from colorectal cancer–there is a difference!. HPB. 8(2). 124–131. 5 indexed citations
8.
Vathsala, Anantharaman, et al.. (2005). Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1. Transplantation. 80(6). 765–774. 90 indexed citations
9.
Tan, Puay Hoon, et al.. (2004). Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology. 45(4). 343–351. 17 indexed citations
10.
Tan, Puay Hoon, Boon Bee George Goh, G.S.C. Chiang, & Boon‐Huat Bay. (2001). Correlation of Nuclear Morphometry with Pathologic Parameters in Ductal Carcinoma In Situ of the Breast. Modern Pathology. 14(10). 937–941. 50 indexed citations
11.
Woo, Keng-Thye, et al.. (2000). ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney International. 58(6). 2485–2491. 84 indexed citations
12.
Chiang, G.S.C., et al.. (2000). Pathologic-radiologic correlations in screen-detected ductal carcinoma in situ of the breast: Findings of the Singapore breast screening project. International Journal of Cancer. 90(4). 231–236. 18 indexed citations
13.
Tan, Puay Hoon, et al.. (1999). Screen detected breast cancer in an Asian population: pathological findings of the Singapore breast screening project. The Breast. 8(3). 120–125. 11 indexed citations
16.
Lau, Gilbert, Soo‐Yong Tan, G.S.C. Chiang, & Wee Teng Poh. (1998). Bronchioloalveolar carcinoma with metastasis to the pituitary gland: a case report.. Journal of Clinical Pathology. 51(12). 931–934. 16 indexed citations
17.
Chiang, G.S.C., et al.. (1994). Pathology of urinary tract malformations in a paediatric autopsy series.. PubMed. 23(6). 838–43. 8 indexed citations
18.
Low, Poh‐Sim, et al.. (1989). Accuracy of Anorectal Manometry in the Diagnosis of Hirschsprung's Disease. Journal of Pediatric Gastroenterology and Nutrition. 9(3). 342–346. 4 indexed citations
19.
Woo, Keng Thye, et al.. (1989). Protein Selectivity: A Prognostic Index in IgA Nephritis. ˜The œNephron journals/Nephron journals. 52(4). 300–306. 19 indexed citations
20.
Yap, Hui‐Kim, Rebecca Sakai, Valerie J. Rappaport, et al.. (1988). Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: Frequency and clinical significance. Clinical Immunology and Immunopathology. 49(3). 450–462. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026